Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
114597142 | 11459714 | 2 | F | 20110303 | 20160720 | 20150904 | 20160725 | EXP | US-TAKEDA-2014TUS006876 | TAKEDA | 0.00 | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
114597142 | 11459714 | 1 | PS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 15 MG, UNK | 21073 | 15 | MG | TABLET | |||||||
114597142 | 11459714 | 2 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 1000 MG, UNK | U | 0 | 1000 | MG | ||||||||
114597142 | 11459714 | 3 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | 1000 MG, UNK | U | 0 | 1000 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
114597142 | 11459714 | 1 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
114597142 | 11459714 | OT |
114597142 | 11459714 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
114597142 | 11459714 | Bladder cancer | |
114597142 | 11459714 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
114597142 | 11459714 | 1 | 200702 | 200901 | 0 | |
114597142 | 11459714 | 2 | 1999 | 2011 | 0 | |
114597142 | 11459714 | 3 | 1999 | 2011 | 0 |